The collaborative hospital transfusion study: Variations in use of autologous blood account for hospital differences in red cell use during primary hip and knee surgery

Transfusion

Volumn 38, Issue 6, 1998, Pages 530-539

  Churchill, W H ^a,b   McGurk, S ^a   Chapman, R H ^c   Wallace, E L ^d   Bertholf, M F ^e   Goodnough, L T ^f   Kao, K J ^g   Olson, J D ^h   Woodson, R D ⁱ   Surgenor, D M ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD CENTER FOR RISK ANALYSIS   (United States)

^d CMS Inc   (United States)

^e Florida Georgia Blood Alliance   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

ⁱ UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE POLICY; HEMATOCRIT; HIP SURGERY; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE SURGERY; MAJOR CLINICAL STUDY; MALE; TOTAL KNEE REPLACEMENT;

EID: 20244366365     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38698326332.x     Document Type: Article

References (22)

1. Kruskall MS, Glazer EE, Leonard SS, et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion 1986;26:335-40.
2. Consensus conference. Perioperative red blood cell transfusion. JAMA 1988;260:2700-3.
3. The use of autologous blood. The National Blood Resource Education Program Expert Panel. JAMA 1990;263:414-7.
4. Wallace EL, Surgenor DM, Hao SH, et al. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993;33:139-44.
5. Wallace EL, Churchill WH, Surgenor DM, et al. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802-12.
6. Kruskall MS, Yomtovian R, Dzik W, et al. On improving the cost-effectiveness of autologous blood transfusion practices. Transfusion 1994;34:259-64.
7. Birkmeyer JD, Goodnough LT, AuBuchon JP, et al. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993;33:544-51.
8. Etchason J, Petz L, Keller E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995;332:719-24.
9. Churchill WH, Chapman RH, Rutherford CJ, et al. Blood product utilization in hip and knee arthroplasty: effect of gender and autologous blood on transfusion practice. Vox Sang 1994;66:182-7.
10. Surgenor DM, Wallace EL, Churchill WH, et al. Red cell transfusions in total knee and total hip replacement surgery. Transfusion 1991;31:531-7.
11. Surgenor DM, Churchill WH, Wallace EL, et al. Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study. Transfusion 1996;36:521-32.
12. DRGs, diagnosis related groups: definitions manual. Eleventh revision. New Haven, CT: Health Systems International, 1994.
13. International classification of diseases, Ninth Revision. Clinical modification: ICD-9-CM 4th ed. DHHS publication no.(PHS) 80-1260. Washington: Government Printing Office, 1993.
14. Nuttall GA, Santrach PJ, Oliver WC Jr, et al. The predictors of red cell transfusions in total hip arthroplasties. Transfusion 1996;36:144-9.
15. Churchill WH, Surgenor DM, Wallace EL. Methods must match the mission (editorial). Transfusion 1994;34:460-1.
16. Goodnough LT, Verbrugge D, Vizmeg K, Riddell J 4th. Identifying elective orthopedic surgical patients transfused with amounts of blood in excess of need: the transfusion trigger revisited. Transfusion 1992;32:648-53.
17. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1996;333:1721-5.
18. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. Risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.
19. Lee SJ, Neumann PJ, Churchill WH, et al. Patients' willingness to pay for autologous blood donation. Health Policy 1997;40:1-12.
20. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: Do we have the answers yet? (editorial). Transfusion 1997;37:121-5.
21. Gould SA, Forbes JM. Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: pro. Transfusion 1995;35:446-9.
22. Miller RD, von Ehrenburg W. Controversies in transfusion medicine: indications for autologous and allogeneic transfusion should be the same: con. Transfusion 1995;35:450-2.